Jan 18, 2023–RhoVac AB (under name change to Chosa Oncology AB) has completed the acquisition of Chosa ApS and a new board and CEO have taken office (regulatory)Dec 27, 2022–RhoVac’s co-founder Anders Ljungqvist has passed awayDec 05, 2022–RhoVac AB conducts conditional reverse takeover of Chosa ApS (regulatory)
